Abcam
Abcam produces antibodies, proteins, kits and reagent solutions for life science industry.
Business Model:
Revenue: $425.5M
Employees: 1,001-5,000
Industries / Tags:
Detailed Abcam Information
Geographic Data
Address: Cambridge Biomedical Campus
City: Cambridge
State: england
Zip: CB2 0AX
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$257M
Raised Total:$157M
Social
Metrics
68,199Website Global Rank
1,468,132Website Monthly Traffic
Twitter Followers
Description
Abcam produces antibodies, proteins, kits and reagent solutions for life science industry.
Contact Phone:
Contact Email:
Abcam went public on 10/21/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/21/2020
IPO Valuation:
$4B
Ticker Symbol:
ABCM
IPO Price:
$17.5/share
Amount Raised:
$157M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Name | Price |
|---|---|---|
| 8/2021 | Biovision | |
| 3/2020 | Marker Gene Technologies | |
| 11/2019 | Expedeon | |
| 1/2019 | Calico Biolabs | |
| 11/2015 | AxioMx | |
| 1/2015 | Firefly BioWorks | |
| 3/2012 | Epitomics | |
| 9/2011 | Ascent Scientific | |
| 5/2011 | MitoSciences |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
